Avsana Labs, formed September 30, 2020, is a biotechnology startup and spin-out company from the University of Texas at Dallas (UT Dallas) that seeks to improve viral diagnostic testing and environmental viral monitoring using a cutting edge digital nanobubble methodology. The company aims to follow an accelerated path in bringing the technology to market, in collaboration with UT Dallas and the University of Texas Southwestern Medical School.
By leveraging the technology being developed under an R01 NIAID grant to UT Dallas, Avsana intends to enable a significant societal benefit by helping to mitigate the spread of contagious viral infections, while ultimately helping to reduce the loss of life caused by both current and future pandemics. The aim is to develop a significantly improved testing capability, in terms of speed, accuracy, and cost-effectiveness, for both existing and future viruses.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 17217 Waterview Pkwy, Ste 1.202, Dallas,texas 75252-8004,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.avsana.com
- Keywords
- Raleigh.
- HQ
- Dallas, Texas
Avsana Labs Questions
Avsana Labs's website is https://www.avsana.com
Avsana Labs's LinkedIn profile is https://www.linkedin.com/company/avsana-labs
Avsana Labs has
6 employees.
View email and phone details for 6
employees at Avsana Labs.
Avsana Labs's industry is
Biotechnology Research
Avsana Labs's top competitors are
Amicis Research Center,
Pixcan,
Eurofins Pss Insourcing Solutions,
Dynacare,
Nanopaint, Lda.,
Proints,
Biodfw,
Propharma,
High-Tech High Heels,
Beamagine S.l..
Avsana Labs's categories are Biotechnology Research
Avsana Labs's founding year is 2020
